TABLE 1.
Reduction of psychotic symptoms assessed by PANSS after treatment with olanzapine for 4 wk.
| Baseline | Follow-up | Reduction rate | p valuea | |
|---|---|---|---|---|
| Age (years) | 27.4 ± 7.6 | |||
| Education (years) | 9.1 ± 3.5 | |||
| BMI (kg/m2) | 21.0 ± 3.6 | |||
| Onset age (years) | 26.4 ± 8.9 | |||
| Clinical symptoms | ||||
| P subscore | 25.0 ± 6.0 | 16.4 ± 5.2 | 0.33 | <0.001 |
| N subscore | 17.1 ± 4.7 | 15.6 ± 4.3 | 0.04 | 0.23 |
| G subscore | 39.7 ± 7.5 | 32.0 ± 6.0 | 0.17 | <0.001 |
| Total score | 81.8 ± 13.9 | 63.9 ± 13.8 | 0.21 | <0.001 |
PANSS the positive and negative syndrome scale.
a
Comparison of psychotic symptoms between baseline and follow-up.